Sign In
Buy BNOX
$0.253
+0 (+0%)
At Close: Mar 26, 2025
BNC210 demonstrated a statistically significant improvement in post-traumatic stress disorder (PTSD) symptom severity with a clinically meaningful effect size suggesting a potential advantage over app
Bionomics to Present at the 2024 BIO CEO & Investor Conference
04:30pm, Thursday, 22'nd Feb 2024
ADELAIDE, Australia and CAMBRIDGE, Mass., Feb. 22, 2024 (GLOBE NEWSWIRE) -- Bionomics Limited (Nasdaq: BNOX) (Bionomics or Company), a clinical-stage biotechnology company developing novel, first-in-c
7 Strong Buy Stocks Under $20: February 2024
11:01am, Sunday, 04'th Feb 2024
Small-cap stocks are particularly vulnerable to higher interest rates. So it's not surprising that many of these stocks are struggling in a higher-for-longer rate environment.
Bionomics Provides a Review of 2023 and of 2024 Plans
06:00am, Monday, 22'nd Jan 2024
Positive Phase 2b data announced for BNC210 on reduction of total symptom severity and multiple symptom clusters in post-traumatic stress disorder (PTSD), with a discussion with the U.S. Food & Drug A
Bionomics to Present at Biotech Showcase™ 2024
06:00am, Friday, 05'th Jan 2024
The Company will provide an update on its leading asset BNC210 and their partnership strategy The Company will provide an update on its leading asset BNC210 and their partnership strategy
ADELAIDE, Australia and CAMBRIDGE, Mass., Dec. 06, 2023 (GLOBE NEWSWIRE) -- Bionomics Limited (Nasdaq: BNOX) (Bionomics or Company), a clinical-stage biotechnology company developing novel, first-in-c
ADELAIDE, Australia, and CAMBRIDGE, Mass., Oct. 16, 2023 (GLOBE NEWSWIRE) -- Bionomics Limited (Nasdaq: BNOX) (Bionomics or Company), a clinical-stage biotechnology company developing novel, first-in
Penny Stocks To Buy? 3 That Insiders Are Investing $100,000+ In Now
11:51am, Wednesday, 04'th Oct 2023
When constructing a watch list of penny stocks, it is wise to closely monitor any legal insider trading activity. Though the rules surrounding insider trades are complex, legal filings by company exec
Bionomics (BNOX) Meets Goals in PTSD Study, Stock Rallies 244%
10:31am, Friday, 29'th Sep 2023
Bionomics (BNOX) announces positive top-line results from its mid-stage study of BNC210 for the treatment of Post-Traumatic Stress Disorder. The stock of the company rallies 244%.
Bionomics shares soar almost 400% after positive phase IIb results from PTSD treatment
10:00am, Thursday, 28'th Sep 2023
Shares of Bionomics Limited rocketed 387% after phase IIb trial results showed its lead asset had the potential to become a best-in-class treatment for post-traumatic stress disorder (PTSD). Researche
Why Is Bionomics (BNOX) Stock Up 347% Today?
08:03am, Thursday, 28'th Sep 2023
Bionomics (NASDAQ: BNOX ) stock is rocketing higher on Thursday alongside results from a clinical trial. The clinical-stage biotechnology company revealed results from its Phase 2b ATTUNE trial of BN
Bionomics announces positive results in trial of treatment for PTSD
06:13am, Thursday, 28'th Sep 2023
The stock of microcap Bionomics Ltd. rose 36% early Thursday, after the company reported positive results from a mid-stage trial of a treatment for post-traumatic stress disorder.
ATTUNE trial met its primary endpoint showing BNC210 treatment led to a statistically significant reduction in total PTSD symptom severity at 12 weeks.
Bionomics Announces Update on the α7 Nicotinic Acetylcholine Receptor (nAChR) Positive Allosteric Modulator (PAM) Collaboration with MSD
06:00am, Thursday, 14'th Sep 2023
ADELAIDE, Australia, and CAMBRIDGE, Mass., Sept. 14, 2023 (GLOBE NEWSWIRE) -- Bionomics Limited (Nasdaq: BNOX) (Bionomics or Company), a clinical-stage biotechnology company developing novel, first-i
Bionomics (BNOX) Up on Positive Updates on PTSD & SAD Candidate
01:32pm, Thursday, 24'th Aug 2023
Bionomics (BNOX) gains as it provides updates on further development of its lead pipeline candidate, BNC210, developed for post-traumatic stress disorder and social anxiety disorder.
